Asset Management
Compare Stocks
4 / 10Stock Comparison
CNS vs DHIL vs VRTS vs GROW
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management - Global
CNS vs DHIL vs VRTS vs GROW — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Asset Management | Asset Management | Asset Management | Asset Management - Global |
| Market Cap | $3.63B | $473M | $949M | $35M |
| Revenue (TTM) | $517M | $158M | $831M | $8M |
| Net Income (TTM) | $164M | $49M | $138M | $98K |
| Gross Margin | 46.8% | 96.0% | 74.9% | 41.7% |
| Operating Margin | 33.4% | 38.4% | 17.4% | -35.3% |
| Forward P/E | 20.8x | 9.5x | 5.5x | — |
| Total Debt | $141M | $6.40B | $2.84B | $83K |
| Cash & Equiv. | $183M | $42M | $477M | $25M |
CNS vs DHIL vs VRTS vs GROW — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cohen & Steers, Inc. (CNS) | 100 | 111.9 | +11.9% |
| Diamond Hill Invest… (DHIL) | 100 | 164.0 | +64.0% |
| Virtus Investment P… (VRTS) | 100 | 152.5 | +52.5% |
| U.S. Global Investo… (GROW) | 100 | 125.4 | +25.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CNS vs DHIL vs VRTS vs GROW
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CNS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 5.7%, EPS growth 14.2%
- 154.3% 10Y total return vs VRTS's 142.6%
- NIM 2.4% vs DHIL's 0.7%
- 5.7% NII/revenue growth vs GROW's -23.1%
DHIL is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.
- Lower volatility, beta 0.57, current ratio 75115.85x
- Beta 0.57, yield 5.7%, current ratio 75115.85x
- Beta 0.57 vs VRTS's 1.14
- +33.8% vs VRTS's -5.5%
VRTS is the clearest fit if your priority is income & stability and valuation efficiency.
- Dividend streak 7 yrs, beta 1.14, yield 6.6%
- PEG 0.38 vs CNS's 16.52
- Lower P/E (5.5x vs 9.5x), PEG 0.38 vs 1.14
- 6.6% yield, 7-year raise streak, vs CNS's 3.3%
GROW lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.7% NII/revenue growth vs GROW's -23.1% | |
| Value | Lower P/E (5.5x vs 9.5x), PEG 0.38 vs 1.14 | |
| Quality / Margins | Efficiency ratio 0.1% vs GROW's 0.8% (lower = leaner) | |
| Stability / Safety | Beta 0.57 vs VRTS's 1.14 | |
| Dividends | 6.6% yield, 7-year raise streak, vs CNS's 3.3% | |
| Momentum (1Y) | +33.8% vs VRTS's -5.5% | |
| Efficiency (ROA) | Efficiency ratio 0.1% vs GROW's 0.8% |
CNS vs DHIL vs VRTS vs GROW — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CNS vs DHIL vs VRTS vs GROW — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
DHIL leads in 2 of 6 categories
VRTS leads 2 • CNS leads 2 • GROW leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
DHIL leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
VRTS is the larger business by revenue, generating $831M annually — 98.3x GROW's $8M. DHIL is the more profitable business, keeping 30.9% of every revenue dollar as net income compared to GROW's -4.0%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $517M | $158M | $831M | $8M |
| EBITDAEarnings before interest/tax | $198M | $62M | $205M | -$2M |
| Net IncomeAfter-tax profit | $164M | $49M | $138M | $98,000 |
| Free Cash FlowCash after capex | -$94M | $44.5B | -$67M | -$235,000 |
| Gross MarginGross profit ÷ Revenue | +46.8% | +96.0% | +74.9% | +41.7% |
| Operating MarginEBIT ÷ Revenue | +33.4% | +38.4% | +17.4% | -35.3% |
| Net MarginNet income ÷ Revenue | +29.2% | +30.9% | +16.7% | -4.0% |
| FCF MarginFCF ÷ Revenue | +16.4% | -57.4% | -8.9% | -9.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +5.2% | +25.3% | +10.9% | — |
Valuation Metrics
VRTS leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 7.1x trailing earnings, VRTS trades at a 70% valuation discount to CNS's 23.9x P/E. Adjusting for growth (PEG ratio), VRTS offers better value at 0.48x vs CNS's 19.03x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $3.6B | $473M | $949M | $35M |
| Enterprise ValueMkt cap + debt − cash | $3.6B | $6.8B | $3.3B | $10M |
| Trailing P/EPrice ÷ TTM EPS | 23.94x | 9.77x | 7.10x | -104.80x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.79x | 9.48x | 5.55x | — |
| PEG RatioP/E ÷ EPS growth rate | 19.03x | 1.18x | 0.48x | — |
| EV / EBITDAEnterprise value multiple | 19.48x | 110.39x | 16.20x | — |
| Price / SalesMarket cap ÷ Revenue | 7.01x | 3.00x | 1.14x | 4.14x |
| Price / BookPrice ÷ Book value/share | 6.30x | 2.70x | 0.95x | 0.77x |
| Price / FCFMarket cap ÷ FCF | 42.64x | — | — | — |
Profitability & Efficiency
CNS leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CNS delivers a 28.3% return on equity — every $100 of shareholder capital generates $28 in annual profit, vs $0 for GROW. GROW carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to DHIL's 36.26x. On the Piotroski fundamental quality scale (0–9), DHIL scores 6/9 vs GROW's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +28.3% | +27.0% | +13.5% | +0.2% |
| ROA (TTM)Return on assets | +20.5% | +19.5% | +3.6% | +0.2% |
| ROICReturn on invested capital | +19.2% | +1.3% | +3.0% | -4.7% |
| ROCEReturn on capital employed | +22.8% | +26.0% | +3.7% | -6.2% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 5 | 2 |
| Debt / EquityFinancial leverage | 0.25x | 36.26x | 2.74x | 0.00x |
| Net DebtTotal debt minus cash | -$42M | $6.4B | $2.4B | -$24M |
| Cash & Equiv.Liquid assets | $183M | $42M | $477M | $25M |
| Total DebtShort + long-term debt | $141M | $6.4B | $2.8B | $83,000 |
| Interest CoverageEBIT ÷ Interest expense | — | — | 2.15x | 600.00x |
Total Returns (Dividends Reinvested)
CNS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DHIL five years ago would be worth $12,834 today (with dividends reinvested), compared to $4,143 for GROW. Over the past 12 months, DHIL leads with a +33.8% total return vs VRTS's -5.5%. The 3-year compound annual growth rate (CAGR) favors CNS at 13.0% vs VRTS's 0.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +12.9% | +2.8% | -9.8% | +7.7% |
| 1-Year ReturnPast 12 months | -5.2% | +33.8% | -5.5% | +27.8% |
| 3-Year ReturnCumulative with dividends | +44.3% | +22.4% | +0.1% | +3.3% |
| 5-Year ReturnCumulative with dividends | +18.2% | +28.3% | -35.0% | -58.6% |
| 10-Year ReturnCumulative with dividends | +154.3% | +55.4% | +142.6% | +67.4% |
| CAGR (3Y)Annualised 3-year return | +13.0% | +7.0% | +0.0% | +1.1% |
Risk & Volatility
DHIL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DHIL is the less volatile stock with a 0.57 beta — it tends to amplify market swings less than VRTS's 1.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DHIL currently trades 100.0% from its 52-week high vs VRTS's 65.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.98x | 0.57x | 1.14x | 0.71x |
| 52-Week HighHighest price in past year | $83.99 | $175.03 | $215.06 | $3.65 |
| 52-Week LowLowest price in past year | $58.39 | $114.11 | $121.61 | $2.10 |
| % of 52W HighCurrent price vs 52-week peak | +84.7% | +100.0% | +65.9% | +71.8% |
| RSI (14)Momentum oscillator 0–100 | 63.1 | 70.5 | 55.4 | 46.5 |
| Avg Volume (50D)Average daily shares traded | 323K | 23K | 101K | 25K |
Analyst Outlook
VRTS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CNS as "Sell", VRTS as "Hold". Consensus price targets imply 15.0% upside for VRTS (target: $163) vs 6.9% for CNS (target: $76). For income investors, VRTS offers the higher dividend yield at 6.58% vs CNS's 3.29%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Sell | — | Hold | — |
| Price TargetConsensus 12-month target | $76.00 | — | $163.00 | — |
| # AnalystsCovering analysts | 13 | — | 11 | — |
| Dividend YieldAnnual dividend ÷ price | +3.3% | +5.7% | +6.6% | +3.5% |
| Dividend StreakConsecutive years of raises | 2 | 1 | 7 | 1 |
| Dividend / ShareAnnual DPS | $2.34 | $9.98 | $9.32 | $0.09 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | +3.6% | +6.3% | +5.6% |
DHIL leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). VRTS leads in 2 (Valuation Metrics, Analyst Outlook).
CNS vs DHIL vs VRTS vs GROW: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CNS or DHIL or VRTS or GROW a better buy right now?
For growth investors, Cohen & Steers, Inc.
(CNS) is the stronger pick with 5. 7% revenue growth year-over-year, versus -23. 1% for U. S. Global Investors, Inc. (GROW). Virtus Investment Partners, Inc. (VRTS) offers the better valuation at 7. 1x trailing P/E (5. 5x forward), making it the more compelling value choice. Analysts rate Virtus Investment Partners, Inc. (VRTS) a "Hold" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CNS or DHIL or VRTS or GROW?
On trailing P/E, Virtus Investment Partners, Inc.
(VRTS) is the cheapest at 7. 1x versus Cohen & Steers, Inc. at 23. 9x. On forward P/E, Virtus Investment Partners, Inc. is actually cheaper at 5. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Virtus Investment Partners, Inc. wins at 0. 38x versus Cohen & Steers, Inc. 's 16. 52x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CNS or DHIL or VRTS or GROW?
Over the past 5 years, Diamond Hill Investment Group, Inc.
(DHIL) delivered a total return of +28. 3%, compared to -58. 6% for U. S. Global Investors, Inc. (GROW). Over 10 years, the gap is even starker: CNS returned +154. 3% versus DHIL's +55. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CNS or DHIL or VRTS or GROW?
By beta (market sensitivity over 5 years), Diamond Hill Investment Group, Inc.
(DHIL) is the lower-risk stock at 0. 57β versus Virtus Investment Partners, Inc. 's 1. 14β — meaning VRTS is approximately 98% more volatile than DHIL relative to the S&P 500. On balance sheet safety, U. S. Global Investors, Inc. (GROW) carries a lower debt/equity ratio of 0% versus 36% for Diamond Hill Investment Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CNS or DHIL or VRTS or GROW?
By revenue growth (latest reported year), Cohen & Steers, Inc.
(CNS) is pulling ahead at 5. 7% versus -23. 1% for U. S. Global Investors, Inc. (GROW). On earnings-per-share growth, the picture is similar: Virtus Investment Partners, Inc. grew EPS 18. 2% year-over-year, compared to -126. 6% for U. S. Global Investors, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CNS or DHIL or VRTS or GROW?
Diamond Hill Investment Group, Inc.
(DHIL) is the more profitable company, earning 30. 9% net margin versus -4. 0% for U. S. Global Investors, Inc. — meaning it keeps 30. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DHIL leads at 38. 4% versus -35. 3% for GROW. At the gross margin level — before operating expenses — DHIL leads at 96. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CNS or DHIL or VRTS or GROW more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Virtus Investment Partners, Inc. (VRTS) is the more undervalued stock at a PEG of 0. 38x versus Cohen & Steers, Inc. 's 16. 52x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Virtus Investment Partners, Inc. (VRTS) trades at 5. 5x forward P/E versus 20. 8x for Cohen & Steers, Inc. — 15. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VRTS: 15. 0% to $163. 00.
08Which pays a better dividend — CNS or DHIL or VRTS or GROW?
All stocks in this comparison pay dividends.
Virtus Investment Partners, Inc. (VRTS) offers the highest yield at 6. 6%, versus 3. 3% for Cohen & Steers, Inc. (CNS).
09Is CNS or DHIL or VRTS or GROW better for a retirement portfolio?
For long-horizon retirement investors, Diamond Hill Investment Group, Inc.
(DHIL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 57), 5. 7% yield). Both have compounded well over 10 years (DHIL: +55. 4%, VRTS: +142. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CNS and DHIL and VRTS and GROW?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CNS is a small-cap income-oriented stock; DHIL is a small-cap deep-value stock; VRTS is a small-cap deep-value stock; GROW is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.